Anna Fournier

417 total citations
15 papers, 268 citations indexed

About

Anna Fournier is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Anna Fournier has authored 15 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Anna Fournier's work include HIV/AIDS Research and Interventions (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Anna Fournier is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Anna Fournier collaborates with scholars based in France, Switzerland and United States. Anna Fournier's co-authors include Renaud Verdon, J Rougerie, Jean‐Jacques Parienti, Jocelyn Michon, Laurent Hocqueloux, Arnaud de La Blanchardière, Thiérry Prazuck, Aurélie Baldolli, E. Mortier and Apolline Kazémi and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Anna Fournier

14 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Fournier France	8	112	109	71	55	34	15	268
Vincent Petit France	7	85 0.8×	52 0.5×	81 1.1×	16 0.3×	7 0.2×	36	263
Harshad Arvind Vanjare India	10	86 0.8×	117 1.1×	20 0.3×	57 1.0×	7 0.2×	25	250
L. V. Simhachalam Kutikuppala India	10	40 0.4×	90 0.8×	12 0.2×	21 0.4×	32 0.9×	63	270
Jonathan Williams United States	9	57 0.5×	209 1.9×	13 0.2×	27 0.5×	3 0.1×	28	345
Uzma Ishaq Pakistan	9	45 0.4×	113 1.0×	26 0.4×	19 0.3×	36 1.1×	24	256
Hardik Dineshbhai Desai India	8	51 0.5×	59 0.5×	10 0.1×	35 0.6×	5 0.1×	52	200
Jacquita S. Affandi Australia	11	180 1.6×	87 0.8×	19 0.3×	35 0.6×	154 4.5×	30	379
Shashikala Sangle India	9	65 0.6×	195 1.8×	5 0.1×	20 0.4×	10 0.3×	23	339
Terry-Nan Tannenbaum Canada	4	163 1.5×	185 1.7×	51 0.7×	42 0.8×		5	308
Carlos Dueñas Spain	10	73 0.7×	159 1.5×	6 0.1×	34 0.6×	16 0.5×	29	236

Countries citing papers authored by Anna Fournier

Since Specialization

Citations

This map shows the geographic impact of Anna Fournier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Fournier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Fournier more than expected).

Fields of papers citing papers by Anna Fournier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Fournier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Fournier. The network helps show where Anna Fournier may publish in the future.

Co-authorship network of co-authors of Anna Fournier

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Fournier. A scholar is included among the top collaborators of Anna Fournier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Fournier. Anna Fournier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Baldolli, Aurélie, Anna Fournier, Renaud Verdon, & Jocelyn Michon. (2022). Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine. Clinical Microbiology and Infection. 28(6). 885.e1–885.e5. 2 indexed citations

Michon, Jocelyn, Aurélie Baldolli, Évelyne Emery, et al.. (2022). Medicosurgical management of deep wound infections after thoracolumbar instrumentation: risk factors of poor outcomes. Acta Neurochirurgica. 164(3). 881–890.

Bonhomme, Julie, et al.. (2022). Association between Following the ESCMID Guidelines for the Management of Candidemia and Mortality: A Retrospective Cohort Study. Journal of Fungi. 8(5). 541–541. 3 indexed citations

Fournier, Anna, Laurent Hocqueloux, Dominique L. Braun, et al.. (2022). Dolutegravir Monotherapy as Maintenance Strategy: A Meta-Analysis of Individual Participant Data From Randomized Controlled Trials. Open Forum Infectious Diseases. 9(6). ofac107–ofac107. 11 indexed citations

Hocqueloux, Laurent, Sandrine Lefeuvre, Laure Peyro‐Saint‐Paul, et al.. (2022). Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study. Journal of Antimicrobial Chemotherapy. 78(1). 161–168. 9 indexed citations

Parienti, Jean‐Jacques, Thiérry Prazuck, Laure Peyro‐Saint‐Paul, et al.. (2021). Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial. EClinicalMedicine. 38. 100993–100993. 37 indexed citations

Blanchardière, Arnaud de La, Julia Dina, Karl Stéfic, et al.. (2021). Case Report: Leishmania and HIV Co-Diagnosis: How to Understand Medical History?. Frontiers in Immunology. 12. 669723–669723. 5 indexed citations

Parienti, Jean‐Jacques, Anna Fournier, Manuel Etienne, et al.. (2021). Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication. Open Forum Infectious Diseases. 8(7). ofab316–ofab316. 25 indexed citations

Baldolli, Aurélie, Jocelyn Michon, Renaud Verdon, & Anna Fournier. (2020). Vaccination perception and coverage among healthcare students in France in 2019. BMC Medical Education. 20(1). 508–508. 19 indexed citations

10.

Fournier, Anna, et al.. (2020). Incidence and risk factors for medical care interruption in people living with HIV in a French provincial city. PLoS ONE. 15(10). e0240417–e0240417. 2 indexed citations

11.

Fournier, Anna, Yazdan Yazdanpanah, Renaud Verdon, et al.. (2019). Incidence of and risk factors for medical care interruption in people living with HIV in recent years. PLoS ONE. 14(3). e0213526–e0213526. 7 indexed citations

12.

Elias, Christelle, Anna Fournier, Anca Vasiliù, et al.. (2017). Seasonal influenza vaccination coverage and its determinants among nursing homes personnel in western France. BMC Public Health. 17(1). 634–634. 17 indexed citations

13.

Fournier, Anna, Guillaume Martin‐Blondel, Emmanuèle Lechapt, et al.. (2017). Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature Review. Frontiers in Immunology. 8. 577–577. 34 indexed citations

14.

Fournier, Anna, et al.. (1975). Septicémie et méningite néo-natales à Levinea malonatica. La Nouvelle presse médicale. 4(6). 428–428. 1 indexed citations

15.

Rougerie, J, et al.. (1963). [Intracranial endoscopic explorations].. PubMed. 71. 1225–8. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact